{"disease":{"id":"non-valvular-atrial-fibrillation-nvaf","name":"non valvular atrial fibrillation nvaf"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05022758","title":"A Study to Learn Whether There Are Differences in the Kidney's Ability to Work Properly in Korean Patients With Non-valvular Atrial Fibrillation (Irregular and Often Rapid Heartbeat Not Caused by a Heart Valve Problem) Treated With Rivaroxaban as Compared to Those Treated With Warfarin","phase":"","overall_status":"COMPLETED","enrollment_count":45000,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT05027061","title":"A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan","phase":"","overall_status":"COMPLETED","enrollment_count":11776,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT03234114","title":"Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4)","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":3746,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT03746301","title":"Xarelto on Prevention of Stroke and Non-Central Nervous Systemic Embolism in Renally Impaired Korean Patients With Non-valvular Atrial Fibrillation","phase":"","overall_status":"COMPLETED","enrollment_count":924,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT01598051","title":"Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan","phase":"","overall_status":"COMPLETED","enrollment_count":741,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT05232643","title":"A Study Evaluating the Associations Between Clinical Characteristics and Use of Oral Anticoagulants in Italian Elderly Participants With Non-Valvular Atrial Fibrillation","phase":"","overall_status":"RECRUITING","enrollment_count":720,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT03887780","title":"A Study to Evaluate the Safety and Effectiveness of Rivaroxaban (Xarelto) for Prevention of Stroke and Systemic Embolism in Indian Patients With Non-valvular Atrial Fibrillation (NVAF)","phase":"","overall_status":"COMPLETED","enrollment_count":504,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04356989","title":"Study to Gain Information on the Drug Xarelto for the Prevention of Brain Attack and Blockage of an Artery in the Non-central Nervous System Due to Irregular Heartbeat in Taiwanese Patients Suffering From Decreased Renal Function","phase":"","overall_status":"COMPLETED","enrollment_count":493,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT05204212","title":"Left Atrial Appendage Closure in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic KIDNEY Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":430,"lead_sponsor_name":"Prof. Dr. med. Ingo Eitel","has_results":false},{"nct_id":"NCT07396493","title":"A Prospective, Single-arm Study Evaluating the Endothelialization Effect and Timeline of AnchorMan® Left Atrial Appendage Occluder in Non-valvular Atrial Fibrillation Patients at High Risk of Stroke","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":306,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT02954237","title":"AMPLATZER™ Cardiac Plug Observational Post-Approval Study","phase":"","overall_status":"COMPLETED","enrollment_count":91,"lead_sponsor_name":"Abbott Medical Devices","has_results":true},{"nct_id":"NCT06606275","title":"The Safety and Effectiveness of Warfarin Vs Apixaban in Patients With NVAF/ VTE and ESKD on Dialysis","phase":"","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"Abu Dhabi Health Services Company","has_results":false},{"nct_id":"NCT06725355","title":"To Compare the Pharmacokinetics and Safety After a Single Dose Administration of IN-G00002 and IN-R00002 in Healthy Adult Volunteers","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":60,"lead_sponsor_name":"HK inno.N Corporation","has_results":false},{"nct_id":"NCT07385599","title":"FIM Study of the LAmbre™ II LAA Occluder in Non-Valvular AF Patients","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":10,"lead_sponsor_name":"Lifetech Scientific (Shenzhen) Co., Ltd.","has_results":false}],"total":14},"guidelines":[],"source":"Drug Landscape verified database"}